quinazolines has been researched along with rucaparib in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aherne, W; Anderson, VE; Antoni, L; Boxall, KJ; Caldwell, JJ; Collins, I; Eve, PD; Garrett, MD; Oliver, AW; Pearl, LH; Walton, MI | 1 |
| Beijnen, JH; Durmus, S; Schellens, JH; Schinkel, AH; Sparidans, RW | 1 |
| Cupo, M; Mauritz, M; Mitulovic, G; Węsierska-Gądek, J | 1 |
| Bierbach, U; Ding, S | 1 |
| Gunn, AR; Kolb, AL; Lakin, ND | 1 |
5 other study(ies) available for quinazolines and rucaparib
| Article | Year |
|---|---|
CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Cell Line, Tumor; Checkpoint Kinase 2; Crystallography, X-Ray; Drug Synergism; Enzyme Activation; HCT116 Cells; HeLa Cells; Heterocyclic Compounds, 3-Ring; HT29 Cells; Humans; Models, Molecular; Poly(ADP-ribose) Polymerase Inhibitors; Protein Serine-Threonine Kinases; Quinazolines | 2011 |
Liquid chromatography-tandem mass spectrometric assay for the PARP inhibitor rucaparib in plasma.
Topics: Acetonitriles; Animals; Area Under Curve; Calibration; Chromatography, Liquid; Edetic Acid; Female; Gefitinib; Indoles; Mice; Poly(ADP-ribose) Polymerase Inhibitors; Protein Kinase Inhibitors; Quality Control; Quinazolines; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2014 |
Differential Potential of Pharmacological PARP Inhibitors for Inhibiting Cell Proliferation and Inducing Apoptosis in Human Breast Cancer Cells.
Topics: Apoptosis; Benzamides; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Indoles; Phthalazines; Piperazines; Piperidines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinazolines | 2015 |
Linker design for the modular assembly of multifunctional and targeted platinum(ii)-containing anticancer agents.
Topics: Acridines; Amines; Antineoplastic Agents; Dendrimers; Indoles; Organophosphorus Compounds; Platinum; Quinazolines; Tamoxifen | 2016 |
Redundancy between nucleases required for homologous recombination promotes PARP inhibitor resistance in the eukaryotic model organism Dictyostelium.
Topics: ADP Ribose Transferases; Benzamides; Clone Cells; Cyclin-Dependent Kinase 8; Dictyostelium; DNA Damage; Drug Resistance; Exodeoxyribonucleases; Gene Deletion; Homologous Recombination; Indoles; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protozoan Proteins; Quinazolines; Rad51 Recombinase; Recombinant Proteins | 2017 |